Most cited papers from InterveXion Therapeutics (United States)
What are the most cited papers from InterveXion Therapeutics (United States)?
The most cited paper from InterveXion Therapeutics (United States) is "First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers" (Misty W. Stevens, Ralph L. Henry, Samuel Michael Owens et al., 2014), with 47 citations. Next come "Optimization of a methamphetamine conjugate vaccine for antibody production in mice" (33) and "Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use" (32).
Showing 10 of 10 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers Misty W. Stevens, Ralph L. Henry, Samuel Michael Owens et al. · mAbs | 2 Nov 2014 | 47 |
| 2 | Optimization of a methamphetamine conjugate vaccine for antibody production in mice Misty W. Stevens, Melinda G. Gunnell, Rachel Tawney et al. · International Immunopharmacology | 17 Apr 2016 | 33 |
| 3 | Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use Misty W. Stevens et al. · mAbs | 23 Dec 2013 | 32 |
| 4 | Pharmacological effects of two anti-methamphetamine monoclonal antibodies Elizabeth M. Laurenzana, Misty W. Stevens, John C Frank et al. · Human Vaccines & Immunotherapeutics | 8 Jul 2014 | 14 |
| 5 | Effects of a methamphetamine vaccine, IXT-v100, on methamphetamine-related behaviors Courtney M. Keller, Allyson L. Spence, Misty W. Stevens et al. · Psychopharmacology | 22 Nov 2019 | 9 |
| 6 | Antibody production and pharmacokinetics of METH in rats following vaccination with the METH vaccine, IXT-v100, adjuvanted with GLA-SE Misty W. Stevens, Daniela Rüedi‐Bettschen, Melinda G. Gunnell et al. · Drug and Alcohol Dependence | 30 Aug 2019 | 3 |
| 7 | InterveXion Therapeutics Misty W. Stevens · Human Vaccines & Immunotherapeutics | 8 Mar 2017 | 1 |
| 8 | Discovery and Development of an Anti-methamphetamine Monoclonal Antibody for Use in Treating Methamphetamine Abuse Michael D. Hambuchen, Misty W. Stevens, Melinda G. Gunnell et al. | 18 Dec 2015 | 1 |
| 9 | Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine Michael D. Berquist, Melinda G. Gunnell, Ralph L. Henry et al. · Psychopharmacology | 12 Dec 2025 | 0 |
| 10 | Identifying a Lead Candidate Anti-methamphetamine Monoclonal Antibody for IND-enabling Studies: Cross-reactivity and Locomotor Activity Michael D. Berquist, Melinda G. Gunnell, Ralph L. Henry et al. · Journal of Pharmacology and Experimental Therapeutics | 13 May 2024 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.